During 2013, the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP) followed the biannual decentralised and centralised testing model used in previous years, requesting participating laboratories to collect gonococcal isolates during two periods (April/May and October/November).
On the third meeting of the Hepatitis B and C Network national focal points and experts discussed the enhanced surveillance programme for hepatitis B and C across Europe and explored ways of improving it.
The report presents the results of the zoonoses monitoring activities carried out in 2013 in 32 European countries:eg 28 Member States (MS) and four non-Member States (non-MS) European Free Trade Association (EFTA) countries.
This report presents the results of the fifth round of the external quality assessment scheme for typing of verocytotoxin-producing E. coli (VTEC) (further EQA-5) funded by ECDC.
From 21 to 28 November 2014, nearly 700 organisations across Europe will host activities to increase awareness of the personal and public health benefits of HIV testing. As HIV infection can remain asymptomatic for a long time and a substantial number of infected persons across Europe are unaware of their infection, ECDC supports the aims of this second European HIV testing week.
This report comprises the findings of an external quality assessment for the laboratory diagnosis of diphtheria serology under the European Diphtheria Surveillance Network.
This report describes an external quality assessment in 2013 for the laboratory diagnosis of diphtheria under the European Diphtheria Surveillance Network.
This report summarises the surveillance results for Neisseria gonorrhoeae antimicrobial susceptibility in the EU/EEA. In 2012, 20 EU/EEA Member States participated in Euro-GASP.